A ten-year retrospective study of adult acute leukemia was performed in nonleukemia-specialized centers to determine prognostic factors, length and quality of survival, cause of death, and response to different modes of therapy. Of 200 patients, 9.5% achieved complete remission, 14.0% obtained partial remission, and no response was present in 76.5%. Patients who were 50 years old or more (64.5%) had a significantly lower response rate (P <.005) and survival (P <.05) than the younger age group. Aggressive chemotherapy significantly improved the response rate, as well as survival (P <.001). Quality of life was similar for responders and nonresponders, both spending only one fourth of their survival time in the hospital. Infection was the leading cause of death. The overall ten-year response rate of 23.5% represents a realistic rate in nonleukemia-specialized centers in which the treatment of adult acute leukemia is variable.
(Arch Intern Med 136:1256-1261, 1976)
Enck RE, Bauman AW, Bennett JM. Adult Acute Leukemia: The Rochester (NY) Experience. Arch Intern Med. 1976;136(11):1256–1261. doi:10.1001/archinte.1976.03630110032010
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: